Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$392.8M
+30.6% from 2023
Prescriptions
30K
$13,195.67 per claim
Patients
3,203
1,789 prescribers
Total spending, 2024
$393.2M
$122,654.81 per patient
Medicare prescription drug plans paid $392.8M for Octagam in 2024, for 29,770 prescriptions and refills to 3,203 patients (up 30.6% from 2023). The average cost per claim was $13,195.67.
California had the highest Medicare cost for Octagam in 2024: $58.4M for 4,304 claims, followed by New York ($37.2M).
Nilay R Shah, neurology in Fair Lawn, NJ, had the highest Medicare cost for Octagam in 2024: 463 claims costing $10.7M.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Nilay R Shah Fair Lawn, NJ | Neurology | 463 | 46 | $10.7M |
| Abigail M Stocker Louisville, KY | Gastroenterology | 403 | 44 | $7.3M |
| Mohamed A Khalil Webster, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,338 | 20,034 | 2,301 | $253.7M |
| 2023 | 1,457 | 23,562 | 2,510 | $300.8M |
| 2024 | 1,789 | 29,770 | 3,203 | $392.8M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 365 |
| 30 |
| $5.7M |
| Sadiq L Altamimi Pomona, CA | Neurology | 371 | 55 | $3.2M |
| Mark A Landrio Winchester, VA | Neurology | 174 | 23 | $3.0M |
| Jonathan J Eskenazi Beverly Hills, CA | Neurology | 108 | 33 | $2.6M |
| Sanjaykumar J Hapani Edmond, OK | Medical Oncology | 190 | 23 | $2.5M |
| George W Kariampuzha Tyler, TX | Neurology | 66 | Under 11 | $2.4M |
| William R Mitchell Huntersville, NC | Hematology-Oncology | 251 | 28 | $2.3M |
| Sergei Grando Irvine, CA | Dermatology | 111 | 16 | $2.3M |
| Ruth Ann Vleugels Philadelphia, PA | Dermatology | 97 | Under 11 | $2.1M |
| Mouchir S Harb Las Vegas, NV | Neurology | 130 | 12 | $2.0M |
| Xavier J Caro Northridge, CA | Rheumatology | 122 | 13 | $1.9M |
| Hassan Kaleem Tulsa, OK | Radiation Oncology | 124 | 14 | $1.8M |
| Sami L Khella Philadelphia, PA | Neurology | 120 | Under 11 | $1.7M |
| Adela D Mattiazzi Miami, FL | Nephrology | 87 | 15 | $1.7M |
| Payam Soltanzadeh Los Angeles, CA | Neurology | 133 | Under 11 | $1.7M |
| Ravinder Singh Beverly Hills, CA | Neurology | 41 | Under 11 | $1.7M |
| Andrew W Wong San Antonio, TX | Neurology | 140 | Under 11 | $1.6M |
| Sudhir Aggarwal Paoli, PA | Neurology | 73 | Under 11 | $1.6M |
| Alexander I Zuhoski Riverhead, NY | Medical Oncology | 162 | 18 | $1.5M |
| Satish A Shah Gettysburg, PA | Hematology-Oncology | 193 | 15 | $1.4M |
| Nicholas J Lanciano Johnstown, PA | Neurology | 118 | 13 | $1.4M |
| Manish B Viradia Annandale, NJ | Neurology | 96 | Under 11 | $1.3M |
| Thomas H Brannagan III New York, NY | Neurology | 106 | Under 11 | $1.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Octapharma USA | 16,357 | $201.2M |
| Pfizer US Pharm PFE | 13,073 | $188.3M |
| Pfizer Labs. PFE | 364 | $3.8M |